C Carlomagno
Overview
Explore the profile of C Carlomagno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carlomagno C, Bertazioli D, Gualerzi A, Picciolini S, Banfi P, Lax A, et al.
Sci Rep
. 2021 Mar;
11(1):4943.
PMID: 33654146
The pandemic of COVID-19 is continuously spreading, becoming a worldwide emergency. Early and fast identification of subjects with a current or past infection must be achieved to slow down the...
2.
Carlomagno C, Banfi P, Gualerzi A, Picciolini S, Volpato E, Meloni M, et al.
Sci Rep
. 2020 Jun;
10(1):10175.
PMID: 32576912
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease leading to progressive and irreversible muscle atrophy. The diagnosis of ALS is time-consuming and complex, with the clinical and neurophysiological evaluation accompanied...
3.
Bajetta E, Floriani I, Di Bartolomeo M, Labianca R, Falcone A, Di Costanzo F, et al.
Ann Oncol
. 2014 Apr;
25(7):1373-1378.
PMID: 24728035
Background: Some trial have demonstrated a benefit of adjuvant fluoropirimidine with or without platinum compounds compared with surgery alone. ITACA-S study was designed to evaluate whether a sequential treatment of...
4.
Malapelle U, Carlomagno C, Salatiello M, De Stefano A, De Luca C, Bianco R, et al.
Br J Cancer
. 2012 Jul;
107(4):626-31.
PMID: 22805329
Background: Anti-epidermal growth factor receptor (EGFR) monoclonal antibodies are restricted to KRAS wild-type (WT) metastatic colorectal cancers (mCRCs), usually identified by direct sequencing, that may yield false negative results because...
5.
Barba M, Sperati F, Stranges S, Carlomagno C, Nasti G, Iaffaioli V, et al.
Ann Oncol
. 2011 Nov;
23(7):1838-45.
PMID: 22100694
Background: We investigated pretreatment fasting glucose as a predictor of patients' important outcomes in breast and colorectal cancers undergoing targeted therapies. Patients And Methods: In a historic cohort of 202...
6.
Morabito A, Perrone F, Lauria R, Carlomagno C, Marinelli A, Delaurentiis M, et al.
Oncol Rep
. 2011 May;
1(6):1045-8.
PMID: 21607488
The impact of multicentricity in primary breast cancer on relapse or death after radical or modified radical mastectomy was evaluated in 1336 consecutive patients. Multiple tumor foci were found in...
7.
Pepe S, Ruggiero A, Delaurentiis M, Normanno N, Fiorentino B, Perrone F, et al.
Oncol Rep
. 2011 May;
2(3):345-50.
PMID: 21597738
Paraffin-embedded tissues are used in retrospective studies to evaluate the prognostic significance of DNA-flow cytometry (DNA-FCM) in human breast cancer. Although paraffin-embedded samples yield information on disease-free survival (DFS) and...
8.
Lorusso V, Vici P, Bianco A, Lopez M, Deplacido S, Piano A, et al.
Int J Oncol
. 2011 May;
2(4):531-5.
PMID: 21573588
A multicentric randomized study was conducted to compare the CNF regimen (cyclophosphamide at 600 mg/m2/iv, mitoxantrone at 10 mg/m2/iv, 5-fluorouracil at 600 mg/m2/iv) with the CMF regimen (methotrexate at 40...
9.
Perrone F, Deplacido S, Gallo C, Carlomagno C, Lauria R, Bianco A
Int J Oncol
. 2011 May;
7(5):1129-37.
PMID: 21552942
The overview published in 1999 by the Early Breast Cancer Trialist' Cooperative Group demonstrated that systemic therapy after surgical removal of primary breast tumors prolongs both disease-free and overall survival...
10.
Pignata S, Lauria R, Perrone F, Ferrari E, Biondi E, Maffeo A, et al.
Int J Oncol
. 2011 Apr;
11(1):175-80.
PMID: 21528198
Cisplatin and carboplatin are both active in ovarian cancer with different toxicity profiles; thus, dose intensification may be possible by combining them. The aim of the present study was to...